The Indian National Institute of Virology has developed an analysis to identify antibodies that the body produces in response to SARS-CoV-2 coronavirus infection.
An assay developed in India is capable of detecting immunoglobulins present in blood samples.“This kit has been tested at 2 sites in Mumbai and is highly sensitive and accurate.
In addition, it has the advantage of simultaneously testing 90 samples in 2.5 hours, which allows healthcare providers to quickly begin the necessary steps to separate patients”, – wrote Minister of Health Harsh Wardhan on Twitter.
He added that the technology for the mass production of tests was transferred to pharmaceutical companies, and the main drug control department issued the company permission to produce them.
Indian authorities have abandoned Chinese tests for the detection of antibodies to coronavirus. According to Indian authorities, the tests did not give the sensitivity that was expected. China has denied these allegations.
According to recent data, the number of identified coronavirus infected in India exceeded 67.1 thousand people, including 20.9 thousand people recovered, 2 206 people died.